Inventor
CROSS JASON BRYANT
US12 patents
Patents
12 patentsUS10421765B2Sep 24, 2019
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
UNIV TEXAS7 citations82
US10392376B2Aug 27, 2019
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS7 citations82
US12186324B2Jan 7, 2025
Imidazopiperazine inhibitors of transcription activating proteins
UNIV TEXAS3 citations72
US10899769B2Jan 26, 2021
Imidazopiperazinone inhibitors of transcription activating proteins
UNIV TEXAS3 citations72
US11058688B2Jul 13, 2021
Imidazopiperazine inhibitors of transcription activating proteins
UNIV TEXAS3 citations71
US10800774B2Oct 13, 2020
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS2 citations71
US10800769B2Oct 13, 2020
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS2 citations71
US10745420B2Aug 18, 2020
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
UNIV TEXAS2 citations71
US12559497B2Feb 24, 2026
Imidazopiperazine inhibitors of transcription activating proteins
UNIV TEXAS0 citations61
US12540139B2Feb 3, 2026
Imidazopiperazine inhibitors of transcription activating proteins
UNIV TEXAS0 citations61
US11434233B2Sep 6, 2022
Heterocyclic inhibitors of ATR kinase
UNIV TEXAS0 citations61
US11046649B2Jun 29, 2021
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
UNIV TEXAS0 citations51